REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/15/2026
Back to search
Official data from USPTO
MAYNE PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
08/15/2026
Trademark type
Combined
Nice classes
40, 42
Filing date
08/06/2014
Registration date
08/15/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2023
Last transaction
08/15/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/01/2004
First use in commerce
08/01/2014
Drawing code
3
Owner type
03
Owner location
SALISBURY SOUTH, AU
Examiner
FATHY, DOMINIC
Law office
L40
Current location
TMEG LAW OFFICE 104
Mark description
The mark consists of the wording "MAYNE PHARMA" and a circle design. The wording "MAYNE" is in the color white within a red circle. The wording "PHARMA" is in the color red appearing to the right of the circle.
Holders and representatives
Holders
Mayne Pharma International Pty Ltd
Representatives
Melissa A. Nowak Christensen O'Connor Johnson Kindness
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
(Based on Use in Commerce) Contract manufacturing being custom manufacturing of chemical and pharmaceutical products including solid oral and liquid dosage forms and topical liquid and cream formulations
Class 42
(Based on Use in Commerce) Research and development services relating to chemical and pharmaceutical products; pharmaceutical formulation development services; research and development services relating to pharmaceutical manufacturing processes; testing services related to chemical and pharmaceutical products manufacturequality control testing for othersbatch stability and validation testing
Publications
History of USPTO decisions and trademark events.
53 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/21/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/21/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/21/2023
E815
TEAS SECTION 8 & 15 RECEIVED
09/06/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/15/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/11/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/11/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
08/15/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/11/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/08/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
07/07/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/07/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
07/07/2017
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
07/07/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/08/2016
GNRT
NON-FINAL ACTION E-MAILED
12/08/2016
CNRT
SU - NON-FINAL ACTION - WRITTEN
12/08/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/08/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/07/2016
DPCC
DIVISIONAL PROCESSING COMPLETE
12/07/2016
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
12/02/2016
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
12/02/2016
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
09/13/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/31/2016
IUAF
USE AMENDMENT FILED
08/11/2016
DRRR
DIVISIONAL REQUEST RECEIVED
08/11/2016
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
08/11/2016
EISU
TEAS STATEMENT OF USE RECEIVED
08/11/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/16/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/22/2015
PUBO
PUBLISHED FOR OPPOSITION
12/22/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/02/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/18/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/13/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/21/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/21/2015
ALIE
ASSIGNED TO LIE
10/14/2015
ALIE
ASSIGNED TO LIE
10/06/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/18/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/23/2015
GNRT
NON-FINAL ACTION E-MAILED
05/23/2015
CNRT
NON-FINAL ACTION WRITTEN
05/23/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/07/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/06/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/28/2014
GNRT
NON-FINAL ACTION E-MAILED
11/28/2014
CNRT
NON-FINAL ACTION WRITTEN
11/28/2014
DOCK
ASSIGNED TO EXAMINER
11/19/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/16/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/15/2014
NWAP
NEW APPLICATION ENTERED
08/09/2014
Continuous trademark protection
Get notified about every new filing that threatens MAYNE PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.